2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$51.77+$0.05 (+0.09%)
Price as of Sep 11, 2026 7:47 PM EDT- $5.1BMarket Cap
- -8.07%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$51.77+$0.05 (+0.09%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $51.72 | ||
Change | -$0.54 (-1.03%) | ||
Open | $52.35 | ||
High | $53.21 | ||
Low | $51.62 | ||
Previous Close | $52.26 | ||
Volume | 856,711 | ||
30-Day Average Volume | 1,406,382 | ||
1-Week Change | -7.30% | ||
1-Month Change | -4.35% | ||
1-Year Change | -8.07% | ||
3-Year Change | 1.27% | ||
5-Year Change | -57.16% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $5.1B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$91.2M | ||
Free Cash Flow | -$84.1M | ||
EBIT | -$86.9M | ||
EBITDA | -$82.6M | ||
Net Working Capital | $2.2B | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -65 | ||
Enterprise Value/Revenue | 539 | ||
P/B | 3 | ||
P/E | -55 | ||
PEG | -2 | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -61 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue